Litigation Details for DUSA Pharmaceuticals, Inc. v. Biofrontera Inc. (D. Mass. 2018)
✉ Email this page to a colleague
DUSA Pharmaceuticals, Inc. v. Biofrontera Inc. (D. Mass. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-03-23 |
| Court | District Court, D. Massachusetts | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gaylore Stearns |
| Jury Demand | Both | Referred To | |
| Patents | 6,709,446; 8,216,289 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in DUSA Pharmaceuticals, Inc. v. Biofrontera Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for DUSA Pharmaceuticals, Inc. v. Biofrontera Inc. (D. Mass. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-03-14 | 158 | Memorandum & Order | surface.” Likewise, claim 1 of U.S. Patent No. 6,709,446 (the ’446 patent) discloses “[a]n illuminator . .…disputed claim terms of the two asserted patents – U.S. Patents Nos. 8,216,289 (the 1Specifically… Laws ch. 93A (Count VII). ’289 patent) and 9,723,991 (the ’991 patent). The court heard argument pursuant… THE ASSERTED PATENTS The ’289 and the ’991 patents are both entitled “Illuminator…application for the ’991 patent is a continuation of the application for the ’289 patent, which is itself a | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
